Temuco

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma2 trials
• Childhood cancers1 trial
• Diffuse large B-cell lymphoma1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Enrolling by invitation1 trial
• Terminated1 trial

Lead sponsor

• Sanofi3 trials

Running trials

• Enrolling by invitation

  International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

  NCT05669989· Phase 2· Sanofi· Source

• Active, not recruiting

  SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

  NCT05405166· Phase 3· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma1 recruiting

Closed trials

• Terminated

  A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]

  NCT05179603· Phase 2· Sanofi· Source